X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Chronic wounds represent a significant healthcare challenge globally

Content Team by Content Team
26th June 2024
in Press Statements

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Chronic wounds represent a significant healthcare challenge globally, affecting approximately 2.21 per 1000 people. The burden of these wounds is growing due to factors like aging populations and the increasing prevalence of conditions such as diabetes, vascular diseases, and obesity. Pallav Dave, a regulatory compliance analyst based in Kentucky, USA, has conducted an in-depth review, titled “The Challenges of Chronic Wound Care and Management,” which explores the complexities and hurdles in managing chronic wounds effectively.

Chronic wounds are defined as wounds that do not follow the normal healing process and remain open for extended periods. These wounds, which include vascular ulcers, diabetic ulcers, and pressure ulcers, have a significant impact on patients’ quality of life by causing pain, infections, and even death. For instance, diabetic ulcers have a 40% mortality rate five years post-occurrence, and 85% of all amputations are attributed to ulcers, with diabetic ulcers accounting for 75% of all lower limb amputations.

Dave’s review highlights the multi-faceted nature of chronic wound care, emphasizing the need for a comprehensive understanding of the wound healing process, which includes four stages: hemostasis, inflammation, proliferation, and remodeling. Chronic wounds often stall in the inflammation phase, characterized by excess cytokines, proteases, reactive oxygen species (ROS), and senescent cells, which hinder proper healing.

One of the critical factors in chronic wound management is addressing bacterial biofilms, which are present in up to 90% of chronic wounds. These biofilms, formed by bacteria that attach to the wound bed, create a protective membrane that impedes antibiotic treatment and slows tissue repair. Effective management involves understanding and mitigating various factors that impair wound healing, including diabetes, poor nutrition, smoking, local tissue factors, systemic factors like age and obesity, and ensuring proper wound bed preparation.

Dave advocates for a holistic approach to managing chronic wounds, which includes thorough patient and wound assessments to identify underlying issues and comorbidities. This holistic approach should incorporate proper nutrition, glycemic control for diabetic patients, optimizing mobility for patients with pressure ulcers, and using compression therapy for venous ulcers. Furthermore, wound bed preparation using the Tissue Infection/Inflammation Moisture Imbalance Epithelial Edge Advancement (TIME) concept is crucial for optimizing wound healing.

Infection control remains a critical component, and it is recommended to assume all chronic wounds are infected to provide appropriate care. Swabs and biopsies help diagnose infections accurately, and topical antimicrobials are preferred over systemic ones for treating superficial infections, though caution is advised to prevent antimicrobial resistance.

The research underscores the importance of a multidisciplinary approach to chronic wound care. By integrating comprehensive patient assessments, personalized care plans, and advanced wound management techniques, healthcare providers can significantly improve patient outcomes. Dave’s study promotes a standardized approach to wound care, ensuring consistent and effective treatment protocols that can be adapted globally.

The implementation of the TIME framework and the emphasis on proper debridement techniques are particularly noteworthy. These strategies facilitate faster healing and reduce the risk of complications associated with chronic wounds. Additionally, Dave’s research highlights the role of patient education and lifestyle modifications in managing chronic wounds, ensuring patients are active participants in their care.

About the author

Pallav Dave is a regulatory compliance analyst based in Kentucky, USA. With a deep understanding of healthcare regulations and a commitment to improving patient outcomes, Dave has dedicated his career to addressing complex healthcare challenges. His latest research on chronic wound care and management reflects his expertise in identifying critical issues and advocating for comprehensive, multidisciplinary approaches to enhance healthcare delivery. Dave’s insights contribute significantly to the ongoing efforts to mitigate the burden of chronic wounds and improve the quality of life for affected patients worldwide.

Google scholar link: http://ajdhs.com/index.php/journal/article/view/70

Previous Post

Liquid Biopsy in Cancer Diagnostics: Definition and Advantages

Next Post

4% CAGR Till 2030 For Water & Wastewater Treatment Equipment

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post
4% CAGR Till 2030 For Water & Wastewater Treatment Equipment

4% CAGR Till 2030 For Water & Wastewater Treatment Equipment

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In